FINWIRES · TerminalLIVE
FINWIRES

周四欧洲股市多数下跌;停火前景不明朗,油价上涨

-- 周四,欧洲股市普遍下跌,投资者密切关注中东战事以及霍尔木兹海峡因大部分航运受阻而导致的油价上涨。 斯托克欧洲指数下跌0.4%,德国DAX指数下跌1.4%,英国富时100指数下跌0.3%,法国CAC40指数下跌0.5%,而瑞士市场指数上涨0.1%。 欧盟委员会石油协调小组、成员国和行业代表周三举行会议,表示尽管中东战事引发油价飙升,但该地区的石油供应依然稳定。他们强调,必须保持欧盟层面的透明度和协调性,并避免市场出现任何不必要的混乱。 由于拟议的停火协议前景不明朗,油价再次上涨,能源股从中受益。在伦敦,BP和壳牌的股价分别上涨了3.2%和1.4%;在巴黎,道达尔能源的股价上涨了2.7%;在米兰,埃尼集团的股价上涨了4%。 在企业新闻方面,诺华制药周四表示,将扩大其项目,在全球范围内“难以触及”的社区中寻找和治疗心脏病和癌症患者。 该公司表示,到2030年,诺华的三项社区健康计划将覆盖近30个国家,这些计划旨在弥合低收入、农村和其他社区的医疗服务差距,覆盖范围将扩大近三倍。 在苏黎世,诺华制药的股价上涨了0.3%。 诺和诺德周四表示,欧洲药品管理局已批准更新其Wegovy注射剂的产品信息,允许该药物在最高30摄氏度的受控温度下保存长达48小时。 该公司表示,此前,这种注射剂从生产地到最终使用地,整个分销和交付过程中都必须保持低温。 这家丹麦制药公司的股票在哥本哈根下跌了0.8%。 据彭博社周三晚间援引知情人士报道,在出售用于此次合并的7.65亿美元贷款的谈判因持续的市场动荡而暂停后,由瑞银牵头的贷款集团已为TJC支持的Echo Global Logistics收购ITS Logistics提供了资金。 据报道,知情人士称,瑞银牵头的贷款集团在3月底收购完成后提供了这笔贷款,并补充说,该集团计划稍后尝试将这笔债务银团出售给投资者。 周四,瑞银、TJC和Echo Global Logistics均未立即回复的置评请求。 这家瑞士银行的股价上涨了0.3%。 据媒体援引意大利工会FIM-CISL的数据报道,Stellantis在意大利的工厂第一季度产量同比增长9.5%,达到120,366辆。 报道称,这家汽车制造商预计到2026年将在意大利生产50万辆汽车,高于2025年的约38万辆。 Stellantis的股价在巴黎股市几乎没有变化。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB